Clinical trial · Interventional
The REACH Study: A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors
A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors
NCT03980093CI-TRIAL-00061916completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This pilot trial compares two online interventions to improve adherence to anti-hormonal medication among women with the most common form of breast cancer (estrogen receptor-positive).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Education | Behavioral | — | UNRESOLVED |
| Values | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Education plus Values
- interventionNames
- Behavioral: Education
- Behavioral: Values
- type
- ACTIVE_COMPARATOR
- label
- Education
- interventionNames
- Behavioral: Education
Primary outcomes (1)
- measure
- Medication adherence assessed by electronic pillbox (Wisepill box)
- timeFrame
- Change from baseline through 6 month follow-up
Secondary outcomes (4)
- measure
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria include: 1. Women in Colorado treated for Stage 0 to III estrogen receptor-positive breast cancer who have completed primary cancer treatment (surgery, chemotherapy, and/or radiation) and within the past 2.5 years, have been prescribed anti-hormonal therapy 2. Take their anti-hormonal therapy medication at least occasionally and have at least 1 more year left on their prescription 3. Report at least 1 factor that makes taking their anti-hormonal therapy medication difficult 4. Have internet access
References
Publications (0)
Data not yet available
No reference posted for this study.